Trial Profile
A study investigating effect of intravitreal injection of ranibizumab on peripheral and central (aortic) blood pressures in patients with neovascular age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions
- 21 Nov 2016 New trial record